Walgreens expands access to COVID-19 testing services by offering Pixel by Labcorp® At-Home COVID-19 PCR Kits at no cost through curbside and in-store pickup

DEERFIELD, Ill., May 23, 2022 — Walgreens, in collaboration with the U.S. Department of Health and Human Services (HHS) and Labcorp, a leading global life sciences company, today announced a program to make Pixel by Labcorp®[1] COVID-19 at-home PCR collection kits available for curbside and in-store pickup at more than 1,000 stores nationwide. This program is designed to offer customers access to convenient, reliable testing at no cost and with no insurance or eligibility requirements.  This initiative builds on Walgreens collaboration with HHS and Labcorp to offer COVID-19 at-home collection kits nationwide at no cost to individuals who meet clinical guidelines.[2]

Labcorp launches new test for people with skin cancer

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2022-- Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company.

Labcorp receives emergency use authorization for first non-prescription at-home collection kit for combined COVID-19, flu and RSV detection

BURLINGTON, N.C. --(BUSINESS WIRE)--May 18, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus (RSV), a common but contagious respiratory virus often seen in children.

Labcorp to speak at the UBS 2022 Global Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 17, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Tuesday, May 24 at 2:45 p.m. ET.

Labcorp launches first-of-its-kind at-home collection device for diabetes risk testing

BURLINGTON, N.C. --(BUSINESS WIRE)--May 16, 2022-- There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes.

Labcorp acquires diagnostic clinical laboratory services from AtlantiCare

BURLINGTON, N.C. , and EGG HARBOR TOWNSHIP, N.J. --(BUSINESS WIRE)--May 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their long-term strategic relationship. 

Labcorp to webcast its annual meeting of shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 4, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11 , at 9:00 a.m. ET via the Labcorp Investor Relations website.

Labcorp announces 2022 first quarter results

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the first quarter ended March 31, 2022 , and updated full-year guidance.

Meet Prasanth, U.S. Air Force Reservist and Labcorp Oncology Head

Join us in celebrating National Military Appreciation Month as we recognize the services of our veterans, reservists and active duty members and their families.

Labcorp launches convenient home diagnostic test collection service in collaboration with Getlabs

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 22, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Getlabs for Labcorp, an innovative health care service that combines Labcorp’s diagnostic tests with Getlabs phlebotomy service to conveniently test consumers in the comfort of their own homes.